Charles River Laboratories (CRL) Tops Q2 EPS by 9c; Guides Higher

August 7, 2012 4:53 PM EDT Send to a Friend
Charles River Laboratories (NYSE: CRL) reported Q2 EPS of $0.75, $0.09 better than the analyst estimate of $0.66. Revenue for the quarter came in at $284.7 million versus the consensus estimate of $286.16 million.

Charles River Laboratories sees FY2012 EPS of $2.63-$2.73, versus prior guidance of $2.60-$2.70 and the consensus of $2.69.

For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings

Add Your Comment